Another quadruplet therapy for multiple myeloma: the beginning of the end for autologous haematopoietic stem-cell transplantation?

Lancet Haematol. 2024 Jun;11(6):e392-e393. doi: 10.1016/S2352-3026(24)00097-8. Epub 2024 Apr 24.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Multiple Myeloma* / therapy
  • Thalidomide / therapeutic use
  • Transplantation, Autologous*

Substances

  • Thalidomide